Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more ...

There are way more pythons than hunters to remove them in Florida. But the ones that do kill them can be paid full-time by the FWC.

In the latest close session, Cardinal Health (CAH) was up +1.93% at $202.95. The stock's performance was ahead of the S&P 500's daily gain of 0.88%. Meanwhile, the Dow gained 0.38%, and the Nasdaq, a ...

Cardinal Health Inc.’s stock rose 5% Wednesday, after the drug distributor and medical products maker beat estimates for its fiscal fourth quarter and raised its guidance. Dublin, Ohio-based Cardinal ...

Analysts are saying that Cardinal Health could rise by 2030. Bullish on CAH? Invest in Cardinal Health on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to $1 ...

We recently published 10 Stocks on Jim Cramer’s Radar. Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer recently discussed. In a show where Cramer spent most of the time discussing ...

Please provide your email address to receive an email when new articles are posted on . Children with congenital adrenal hyperplasia have a shorter median height and higher body weight at age 20 years ...

Congenital adrenal hyperplasia (CAH) is a group of inherited conditions in which the adrenal glands cannot make certain hormones, most commonly due to a deficiency of the enzyme 21-hydroxylase. This ...

The treatments for both classic and nonclassic congenital adrenal hyperplasia (CAH) include medication, surgery, and psychological support, or a combination of all three. Some people who have CAH, ...

Management of classic congenital adrenal hyperplasia (CAH) can be a lifelong balancing act, but the most feared life-threatening complication is an acute adrenal insufficiency, also known as an ...